Cypress Capital Management (Wyoming)’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.87K Hold
75
– – ﹤0.01% 158
2026
Q1
$4.85K Buy
+75
New +$5.29K ﹤0.01% 151
2021
Q3
– Sell
-110
Closed -$5K – 271
2021
Q2
$5K Hold
110
– – ﹤0.01% 255
2021
Q1
$5K Sell
110
-435
-80% -$19.9K ﹤0.01% 239
2020
Q4
$23K Buy
+545
New +$19.6K 0.02% 149

Other funds holding HALO

Cypress Capital Management (Wyoming)'s HALO Position: Q2 2026 in Review

Cypress Capital Management (Wyoming) held its Halozyme (HALO) position steady in Q2 2026 at 75 shares worth $5.87K. The position accounts for ﹤0.01% of the portfolio, ranked #158.

Cypress Capital Management (Wyoming) first reported a position in HALO in Q4 2020 and has held it in 5 quarters since. The position peaked at $23K in Q4 2020. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Cypress Capital Management (Wyoming) held 75 shares of Halozyme worth $5.87K as of Q2 2026.
  • Cypress Capital Management (Wyoming) left its Halozyme share count unchanged in Q2 2026.
  • Halozyme made up ﹤0.01% of Cypress Capital Management (Wyoming)'s portfolio in Q2 2026, its #158 holding.
  • Cypress Capital Management (Wyoming) first reported a position in Halozyme in Q4 2020 and has held it in 5 quarters since.
  • Cypress Capital Management (Wyoming)'s Halozyme position peaked at $23K in Q4 2020.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Cypress Capital Management (Wyoming)'s 13F filing for Q2 2026, filed 6 Aug 2026.